Global Checkpoint Inhibitors for Treating Cancer Market Analysis 2013-2018 and Forecast 2019-2024
- 99SGL298Lif2019000076
- Pages: 87
- March 2019
- Total Views:1114
- Region : Global
- 99Strategy
- Market Research Report
Details
Snapshot
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Checkpoint Inhibitors for Treating Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Bristol-Myers Squibb(BMS)
Merck
Roche
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Melanoma treatment
Bladder cancer treatment
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table Of Content
Scope
Table of Contents
1 Industry Overview
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Overview
1.1.2 Development of Checkpoint Inhibitors for Treating Cancer
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Checkpoint Inhibitors for Treating Cancer Market by Type
3.1 By Type
3.1.1 PD-1 inhibitors
3.1.2 PD-L1 inhibitors
3.1.3 CTLA-4 inhibitors
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Checkpoint Inhibitors for Treating Cancer Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
4.2 Merck (Company Profile, Sales Data etc.)
4.3 Roche (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Melanoma treatment
6.1.2 Demand in Bladder cancer treatment
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List Of Figure
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in Volume
Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2018
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2018
Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in Volume
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
List Of Table
Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2024, by Application, in USD Million
Table Major Company List of PD-1 inhibitors
Table Major Company List of PD-L1 inhibitors
Table Major Company List of CTLA-4 inhibitors
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2013-2018, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2013-2018, by Company, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in Volume
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List
Licence Rights
"Single User License
allow one user to read, print, and edit the report
Enterprise License
allow all employees within client's company, to read, print, edit the report"
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Snapshot
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the brakes on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Checkpoint Inhibitors for Treating Cancer by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Bristol-Myers Squibb(BMS)
Merck
Roche
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Melanoma treatment
Bladder cancer treatment
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Scope
Table of Contents
1 Industry Overview
1.1 Checkpoint Inhibitors for Treating Cancer Industry
1.1.1 Overview
1.1.2 Development of Checkpoint Inhibitors for Treating Cancer
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Checkpoint Inhibitors for Treating Cancer Market by Type
3.1 By Type
3.1.1 PD-1 inhibitors
3.1.2 PD-L1 inhibitors
3.1.3 CTLA-4 inhibitors
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.Checkpoint Inhibitors for Treating Cancer Bristol-Myers Squibb(BMS) (Company Profile, Sales Data etc.)
4.2 Merck (Company Profile, Sales Data etc.)
4.3 Roche (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Melanoma treatment
6.1.2 Demand in Bladder cancer treatment
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List Of Figure
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in USD Million
Figure Global Checkpoint Inhibitors for Treating Cancer Market Growth 2013-2018, by Type, in Volume
Figure North America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Market Concentration, in 2018
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer MMarket Concentration, in 2018
Figure South America Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Concentration, in 2018
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Melanoma treatment, 2013-2018, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Bladder cancer treatment, 2013-2018, in Volume
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in USD Million
Figure Checkpoint Inhibitors for Treating Cancer Demand in Others, 2013-2018, in Volume
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure North America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure Europe Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure South America Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview
List Of Table
Table Upstream Segment of Checkpoint Inhibitors for Treating Cancer
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2024, by Application, in USD Million
Table Major Company List of PD-1 inhibitors
Table Major Company List of PD-L1 inhibitors
Table Major Company List of CTLA-4 inhibitors
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Type, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Type, in Volume
Table Bristol-Myers Squibb(BMS) Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Checkpoint Inhibitors for Treating Cancer Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue 2013-2018, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Revenue Share, by Company, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume 2013-2018, by Company, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Demand Forecast 2019-2024, by Application, in Volume
Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Production 2013-2018, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in USD Million
Table Global Checkpoint Inhibitors for Treating Cancer Market 2013-2018, by Region, in Volume
Table Global Checkpoint Inhibitors for Treating Cancer Market Share 2013-2018, by Region, in Volume
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table North America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table Europe Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table South America Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Checkpoint Inhibitors for Treating Cancer Market Size 2013-2018, by Country, in Volume
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in USD Million
Table Checkpoint Inhibitors for Treating Cancer Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List
"Single User License
allow one user to read, print, and edit the report
Enterprise License
allow all employees within client's company, to read, print, edit the report"
INQUIRE FOR COVID-19 IMPACT ANALYSIS
: +91 98100 26150 
Related Reports
Page 220 | 
February 2020
Page 131 | January 2020
Page 118 | November 2019
Page 234 | September 2019
Page 140 | July 2019